The effect of silymarin on telomerase activity in the human leukemia cell line K562

Planta Medica

Volumn 78, Issue 9, 2012, Pages 899-902

  Faezizadeh, Zohreh ^a   Mesbah Namin, Seyed Ali Reza ^a   Allameh, Abdolamir ^a  

^a TARBIAT MODARES UNIVERSITY   (Iran)

Author keywords

apoptosis; Asteraceae; K562; Silybum marianum; silymarin; telomerase activity

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; 4 [5 (4 METHYL 1 PIPERAZINYL)[2,5' BI 1H BENZIMIDAZOL] 2' YL]PHENOL; SILYMARIN; TELOMERASE;

ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CANCER GROWTH; CELL ASSAY; CELL STRAIN K 562; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; TELOMERIC REPEAT AMPLIFICATION PROTOCOL;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; K562 CELLS; LEUKEMIA, ERYTHROBLASTIC, ACUTE; SILYMARIN; TELOMERASE;

ASTERACEAE; SILYBUM MARIANUM;

EID: 84862584725     PISSN: 00320943     EISSN: 14390221     Source Type: Journal    
DOI: 10.1055/s-0031-1298464     Document Type: Article

References (28)

1. Tian X, Chen B, Liu X. Telomere and telomerase as targets for cancer therapy. Appl Biochem Biotechnol: 2010; 160 1460 1472
2. Cheung AL, Deng W. Telomere dysfunction, genome instability and cancer. Front Biosci: 2008; 1 2075 2090 (Pubitemid 351589236)
3. Harley CB. Telomerase and cancer therapeutics. Nat Rev Cancer: 2008; 8 167 179 (Pubitemid 351305939)
4. Zimmermann S, Martens UM. Telomeres and telomerase as targets for cancer therapy. Cell Mol Life Sci: 2007; 64 906 921 (Pubitemid 46597763)
5. Huang ST, Wang CY, Yang RC, Chu CJ, Wu HT, Pang JH. Wogonin, an active compound in Scutellariabai calensis, induces apoptosis and reduces telomerase activity in the HL-60 leukemia cells. Phytomedicine: 2010; 138 1747 1754
6. Ji ZN, Ye WC, Liu GQ, Huang Y. Inhibition of telomerase activity and bcl-2 expression in berbamine-induced apoptosis in HL-60 cells. Planta Med: 2002; 68 596 600 (Pubitemid 34827923)
7. Wang X, Hao MW, Dong K, Lin F, Ren JH, Zhang HZ. Apoptosis induction effects of EGCG in laryngeal squamous cell carcinoma cells through telomerase repression. Arch Pharm Res: 2009; 3 1263 1269
8. Lin SC, Li WC, Shih JW, Hong KF, Pan YR, Lin JJ. The tea polyphenols EGCG and EGC repress mRNA expression of human telomerase reverse transcriptase (hTERT) in carcinoma cells. Cancer Lett: 2006; 236 80 88
9. Ramachandran C, Fonseca HB, Jhabvala P, Escalon EA, Melnick SJ. Curcumin inhibits telomerase activity through human telomerase reverse transcritpase in MCF-7 breast cancer cell line. Cancer Lett: 2002; 184 1 6 (Pubitemid 34718100)
10. Moon DO, Kim MO, Choi YH, Lee HG, Kim ND, Kim GY. Gossypol suppresses telomerase activity in human leukemia cells via regulating hTERT. FEBS Lett: 2008; 582 3367 3373
11. Moon DO, Kim MO, Lee JD, Choi YH, Kim GY. Butein suppresses c-Myc-dependent transcription and Akt-dependent phosphorylation of hTERT in human leukemia cells. Cancer Lett: 2009; 286 172 179
12. Park SE, Park C, Kim SH, Hossain MA, Kim MY, Chung HY, Son WS, Kim GY, Choi YH, Kim ND. Korean red ginseng extract induces apoptosis and decreases telomerase activity in human leukemia cells. J Ethnopharmacol: 2009; 121 304 312
13. Park DI, Lee JH, Moon SK, Kim CH, Lee YT, Cheong J, Choi BT, Choi YH. Induction of apoptosis and inhibition of telomerase activity by aqueous extract from Platycodon grandiflorum in human lung carcinoma cells. Pharmacol Res: 2005; 51 437 443 (Pubitemid 40321012)
14. Zhong X, Zhu Y, Lu Q, Zhang J, Ge Z, Zheng S. Silymarin causes caspases activation and apoptosis in K562 leukemia cells through inactivation of Akt pathway. Toxicology: 2006; 227 211 216 (Pubitemid 44402863)
15. Katiyar SK, Roy AM, Baliga MS. Silymarin induces apoptosis primarily through a P53-dependent pathway involving Bcl-2/Bax, cytochrome C release, and caspase activation. Mol Cancer Ther: 2005; 4 207 216 (Pubitemid 40340200)
16. Mansour HH, Hafez HF, Fahym NM. Silymarin modulate cisplatin-induced oxidative stress and hepatotoxicity in rats. J Biochem Mol Biol: 2006; 39 656 661 (Pubitemid 44892889)
17. Matsuda T, Ferreri K, Todorov I, Kuroda Y, Smith CV, Kandeel F, Mullen Y. Silymarin protects pancreatic betacells against cytokine-mediated toxicity: implication of c-Jun NH2-terminal kinase and janus kinase/signal transducer and activator of transcription pathways. Endocrinology: 2005; 146 175 185 (Pubitemid 40051737)
18. Kiruthiga PV, Shafreen RB, Pandian SK, Devi KP. Silymarin protection against major reactive oxygen species released by environmental toxins: exogenous H2O2 exposure in erythrocytes. Basic Clin Pharmacol Toxicol: 2007; 100 414 419 (Pubitemid 46776391)
19. Ramasamy K, Agarwal R. Multitargeted therapy of cancer by silymarin. Cancer Lett: 2008; 269 352 362
20. Tyagi A, Bhatia N, Condon MS, Bosland MC, Agarwal C, Agarwal R. Antiproliferative and apoptotic effects of silibinin in rat prostate cancer cells. Prostate: 2002; 53 211 217 (Pubitemid 35266181)
21. Ramakrishnan L, Muzio L, Elinos-Baz CM, Jagan S, Augustine TA, Kamaraj S, Anandakumar P, Devaki T. Silymarin inhibited proliferation and induced apoptosis in hepatic cancer cells. Cell Prolif: 2009; 42 229 240
22. Deep G, Agarwal R. Chemopreventive efficacy of silymarin in skin and prostate cancer. Integr Cancer Ther: 2007; 6 130 145 (Pubitemid 46871840)
23. Tyagi A, Raina K, Singh RP, Gu M, Agarwal C, Harrison G, Glode LM, Agarwal R. Chemopreventive effects of silymarin and silibinin on N-butyl-N-(4-hydroxybutyl) nitrosamine induced urinary bladder carcinogenesis in male ICR mice. Mol Cancer Ther: 2007; 6 3248 3255
24. Wen Z, Dumas TE, Schrieber SJ, Hawke RL, Fried MW, Smith PC. Pharmacokinetics and metabolic profile of free, conjugated, and total silymarin flavonolignans in human plasma after oral administration of milk thistle extract. Drug Metab Dispos: 2008; 36 65 72
25. Mor-Tzuntz R, Uziel O, Shpilberg O, Lahav J, Raanani P, Bakhanashvili M, Rabizadeh E, Zimra Y, Lahav M, Granot G. Effect of imatinib on the signal transduction cascade regulating telomerase activity in K562 (BCR-ABL-positive) cells sensitive and resistant to imatinib. Exp Hematol: 2010; 38 27 37
26. Chai JH, Zhang Y, Tan WH, Chng WJ, Li B, Wang X. Regulation of hTERT by BCR-ABL at multiple levels in K562 cells. BMC Cancer: 2011; 11 512 528
27. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Meth: 1983; 65 55 63 (Pubitemid 14203433)
28. Barford MM. Rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem: 1976; 72 248 254